DCF — ROCKLEDGE REGIONAL MEDICAL CENTER
Enterprise Value: $-35.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-35.9M
Enterprise Value
$-16.0M
PV of Cash Flows
$-20.0M
PV of Terminal Value
$-32.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $178.9M | $0.9M | 1.0% | $-6.7M | $-6.1M |
| Year 2 | $184.3M | $2.8M | 2.0% | $-5.0M | $-4.2M |
| Year 3 | $189.8M | $4.8M | 3.0% | $-3.3M | $-2.5M |
| Year 4 | $195.5M | $5.9M | 3.0% | $-2.6M | $-1.8M |
| Year 5 | $201.4M | $6.6M | 3.0% | $-2.4M | $-1.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-35.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$173.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base3.853393183540876e-05
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5